Full Text View
Tabular View
No Study Results Posted
Related Studies
A Randomized Study of Whether Alfuzosin(Xatral) Helps in the Passage of Kidney Stones
This study has been terminated.
Study NCT00583258   Information provided by St. Michael's Hospital, Toronto
First Received: December 20, 2007   Last Updated: August 4, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Kidney Stones
Additional conditions recognized in this trial
Kidney Calculi
More general conditions related to this trial
Calculi
Kidney Diseases
Nephrolithiasis
Pathological Conditions, Anatomical
Urinary Calculi
Urolithiasis
Urologic Diseases
Interventions listed in this trial
Alfuzosin (Xatral)
Placebo Alfuzosin
Additional drug interventions recognized in this trial
Alfuzosin
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic alpha-Antagonists
Adrenergic Antagonists
Antihypertensive Agents
Cardiovascular Agents
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
St. Michael's Hospital, Toronto
Sanofi-Aventis


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services